Physician profile
Parhum Namdaran
NPI 1952797870
$19,392.46
in general payments reported to CMS, 2019-2025
43 companies · $2,559 in 2025
The $2,559 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2020: $210 · 2021: $777 · 2022: $6,710 · 2023: $6,206 · 2024: $2,797 · 2025: $2,559.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Consulting Fee: $1,132 · Travel and Lodging: $416 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,012.96 |
| Consulting Fee | $1,132.00 |
| Travel and Lodging | $415.68 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $3,976.55 | 2021-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Shockwave Medical, INC | $2,065.69 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $1,770.30 | 2019-2025 | Mitraclip, Amplatzer, Xience Skypoint |
| Medtronic, INC. | $1,496.62 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, Symplicity G3 |
| Biotronik INC. | $999.66 | 2021-2023 | Orsiro Mission, Nhancer Rx, Trapit |
| Penumbra, INC. | $936.82 | 2022 | |
| Boston Scientific Corporation | $865.32 | 2021-2024 | Watchman Access System, Synergy, Rotapro |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $856.16 | 2023-2025 | Lifevest |
| Abiomed | $671.72 | 2022-2025 | Impella |
| Cardiovascular Systems INC. | $596.14 | 2021-2023 | Diamondback Coronary, Diamondback Peripheral |
| Astrazeneca Pharmaceuticals Lp | $472.61 | 2021-2024 | Farxiga, Brilinta, Wainua |
| Novartis Pharmaceuticals Corporation | $432.58 | 2023-2025 | |
| Chiesi USA, INC. | $389.44 | 2022-2025 | Kengreal, Cleviprex |
| Amgen INC. | $372.71 | 2023-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $360.96 | 2024-2025 | Jardiance |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aop Health US, LLC | $333.58 | 2025 | Rapiblyk |
| Cook Medical LLC | $332.84 | 2022-2023 | Cook |
| E.R. Squibb & Sons, L.L.C. | $238.40 | 2024-2025 | Camzyos, Eliquis |
| Inari Medical, INC. | $236.07 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Novo Nordisk INC | $211.99 | 2024-2025 | Rybelsus, Ozempic, Wegovy |
| Terumo Medical Corporation | $207.07 | 2022 | |
| Alnylam Pharmaceuticals INC. | $163.95 | 2023-2024 | Amvuttra |
| W. L. Gore & Associates, INC. | $162.95 | 2022-2023 | Gore Cardioform Septal Occluder |
| Heartflow, INC. | $131.28 | 2024-2025 | |
| Kiniksa Pharmaceuticals International, Plc | $116.03 | 2024 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $108.30 | 2024 | |
| Esperion Therapeutics, INC. | $107.63 | 2024-2025 | Nexletol |
| Irhythm Technologies, INC. | $92.51 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Philips North America LLC | $87.93 | 2022-2024 | (5044) Mcot |
| Merck Sharp & Dohme LLC | $85.67 | 2024-2025 | Verquvo |
| Lilly USA, LLC | $75.75 | 2024-2025 | Zepbound, Mounjaro |
| Bayer Healthcare Pharmaceuticals INC. | $63.87 | 2025 | |
| Kestra Medical Technology Services, INC. | $56.27 | 2025 | Assure Wcd |
| Pfizer INC. | $52.26 | 2024-2025 | |
| Teleflex LLC | $50.23 | 2022 | |
| Cleerly, INC. | $47.10 | 2024-2025 | Cleerly Ischemia, Cleerly Labs |
| Scpharmaceuticals INC. | $37.04 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $32.55 | 2024 | |
| Getinge USA Sales, LLC | $25.82 | 2023 | Cardiosave Hybrid, Type B Plug |
| Trevena, INC. | $24.02 | 2022 | |
| Reflow Medical INC | $20.41 | 2025 | |
| Glaxosmithkline, LLC. | $14.13 | 2025 | Arexvy, Shingrix |
| Atricure, INC. | $13.53 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parhum Namdaran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.